Bridgebio Oncology Therapeutics, Inc. (BBOT)
9.98
-0.14
(-1.38%)
USD |
NASDAQ |
Feb 20, 16:00
9.99
+0.01
(+0.10%)
After-Hours: 20:00
Bridgebio Oncology Therapeutics EPS Diluted (Quarterly) : -1.029 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Rapport Therapeutics, Inc. | -0.7098 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -44.76M |
| Total Expenses (Quarterly) | 44.76M |
| Enterprise Value | 332.89M |
| Earnings Yield | -9.29% |
| Normalized Earnings Yield | -9.296 |